Inventor · disambiguated record
Daniel C. Maneval
Also filed as: MANEVAL DANIEL · MANEVAL DANIEL C
12 granted patents·32 pending applications·392 citations·filing 1994–2024
93Inventor score
Top patents by PatentIndex Score
44 records- 0194US5932210ARecombinant adenoviral vector and methods of useCANJI INC·Filed 1997·Granted Aug 3, 1999·151 cites·19 claims
- 0291US10137104B2Combination therapy with an anti-hyaluronan agent and therapeutic agentHALOZYME INC·Filed 2017·Granted Nov 27, 2018·9 cites·30 claims
- 0391US9913822B2Combination therapy with an anti-hyaluronan agent and therapeutic agentMANEVAL DANIEL C·Filed 2013·Granted Mar 13, 2018·23 cites·35 claims
- 0491US6210939B1Recombinant adenoviral vector and methods of useCANJI INC·Filed 1994·Granted Apr 3, 2001·71 cites·25 claims
- 0589US6165779ACompositions and methods for therapeutic useCANJI INC·Filed 1997·Granted Dec 26, 2000·70 cites·9 claims
- 0688US7157079B2Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2004·Granted Jan 2, 2007·32 cites·19 claims
- 0784US7462351B2Nucleic acid deliveryCANJI INC·Filed 2006·Granted Dec 9, 2008·3 cites·26 claims
- 0877US6989268B2Recombinant adenoviral vector and methods of useCANJI INC·Filed 2003·Granted Jan 24, 2006·5 cites·9 claims
- 0972US2007253932A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2007·Application pending·0 cites
- 1071US2007128166A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 1169US2025195506A1Combination therapeutics for antiviral treatmentSELVA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1267US2006039893A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 1367US2009048148A1Compositions and methods for therapeutic useCANJI INC·Filed 2008·Application pending·0 cites
- 1466US7094583B2Nucleic acid deliveryINNOVATA PLC·Filed 2004·Granted Aug 22, 2006·1 cites·26 claims
- 1565US2004266006A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2004·Application pending·0 cites
- 1665US2006099187A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 1764US2009082289A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2007·Application pending·0 cites
- 1864US2008299083A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2007·Application pending·0 cites
- 1964US2007009486A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 2064US2009088398A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2008·Application pending·0 cites
- 2164US2008286239A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2008·Application pending·0 cites
- 2264US2007122379A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2006·Application pending·0 cites
- 2363US2008182807A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 2463US2004087027A1Recombinant adenoviral vector and methods of useCANJI INC·Filed 2003·Application pending·0 cites
- 2563US2007014768A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2006·Application pending·0 cites
- 2663US2006140910A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2005·Application pending·0 cites
- 2762US7041284B2Recombinant adenoviral vector and method of useCANJI INC·Filed 1997·Granted May 9, 2006·13 cites·32 claims
- 2861US2007031381A1Recombinant adenoviral vector and method of useCANJI INC·Filed 2005·Application pending·0 cites
- 2961US2003211598A1Compositions and methods for therapeutic useCANJI INC·Filed 2003·Application pending·0 cites
- 3061US2008175818A1Adenoviral vectors having a protein ix deletionCANJI INC·Filed 2007·Application pending·0 cites
- 3161US2006034804A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3259US2006171925A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3359US2006275261A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3459US2006233759A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3557US2011104118A1Compositions and methods for therapeutic useCANJI INC·Filed 2010·Application pending·0 cites
- 3657US2019083449A1Combination therapy with an anti-hyaluronan agent and therapeutic agentHALOZYME INC·Filed 2018·Application pending·0 cites
- 3755US6331524B1Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapyGENZYME CORP·Filed 1997·Granted Dec 18, 2001·11 cites·4 claims
- 3851US2002081736A1Nucleic acid deliveryFiled 2001·Application pending·0 cites
- 3948US2003064949A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsFiled 2002·Application pending·0 cites
- 4044US2007259429A9Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2001·Application pending·0 cites
- 4141US2005031590A9Adenoviral vectors having a protein IX deletionFiled 2001·Application pending·0 cites
- 4239US7105156B1Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cellsCANJI INC·Filed 1995·Granted Sep 12, 2006·3 cites·11 claims
- 4331US2001006629A1Recombinant adenoviral vector and methods of useFiled 1999·Application pending·0 cites
- 4425US2003060434A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel C. Maneval files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →